BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 35546702)

  • 21. Case Report: Rhino-orbital Mucormycosis Related to COVID-19: A Case Series Exploring Risk Factors.
    Aggarwal SK; Kaur U; Talda D; Pandey A; Jaiswal S; Kanakan A; Singh A; Chakrabarti SS
    Am J Trop Med Hyg; 2021 Dec; 106(2):566-570. PubMed ID: 34902834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determinants of stroke in patients with rhino cerebral mucormycosis seen during the second wave of COVID-19 pandemic: A prospective cohort study.
    Pandey S; Malhotra HS; Garg RK; Sharma K; Rizvi I; Kumar S; Kumar N; Uniyal R; Sharma PK; Gupta P; Jain A; Reddy DH
    J Infect Public Health; 2022 Nov; 15(11):1265-1269. PubMed ID: 36272391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors and outcomes of COVID associated mucormycosis in kidney transplant recipients.
    Bansal SB; Rana A; Babras M; Yadav D; Jha P; Jain M; Sethi SK
    Transpl Infect Dis; 2022 Apr; 24(2):e13777. PubMed ID: 34932870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Features and Mortality of COVID-19-Associated Mucormycosis: A Systematic Review and Meta-Analysis.
    Watanabe A; So M; Mitaka H; Ishisaka Y; Takagi H; Inokuchi R; Iwagami M; Kuno T
    Mycopathologia; 2022 Jun; 187(2-3):271-289. PubMed ID: 35312945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Past, Present and Future of COVID-19 Associated Mucormycosis: A Rapid Review.
    Sarfraz Z; Sarfraz A; Jaiswal V; Poudel S; Bano S; Hanif M; Singh Shrestha P; Sarfraz M; Michel G; Cherrez-Ojeda I
    J Prim Care Community Health; 2022; 13():21501319221099476. PubMed ID: 35587142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pediatric mucormycosis associated with COVID-19: A systematic review of clinical cases.
    Amaral LB; Carlesse F; Rossato L
    Enferm Infecc Microbiol Clin (Engl Ed); 2024; 42(6):321-326. PubMed ID: 38216422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Black fungus immunosuppressive epidemic with Covid-19 associated mucormycosis (zygomycosis): a clinical and diagnostic perspective from India.
    Singh K; Kumar S; Shastri S; Sudershan A; Mansotra V
    Immunogenetics; 2022 Apr; 74(2):197-206. PubMed ID: 34596728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COVID-19-associated mucormycosis: An updated systematic review of literature.
    Pal R; Singh B; Bhadada SK; Banerjee M; Bhogal RS; Hage N; Kumar A
    Mycoses; 2021 Dec; 64(12):1452-1459. PubMed ID: 34133798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A systematic review on SARS-CoV-2-associated fungal coinfections.
    Soni S; Namdeo Pudake R; Jain U; Chauhan N
    J Med Virol; 2022 Jan; 94(1):99-109. PubMed ID: 34570905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Orofacial Mycoses in Coronavirus Disease-2019 (COVID-19): A Systematic Review.
    Samaranayake LP; Fakhruddin KS; Ngo HC; Bandara HMNM; Leung YY
    Int Dent J; 2022 Oct; 72(5):607-620. PubMed ID: 35367044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COVID-19-associated rhino-orbital-cerebral mucormycosis: A systematic review, meta-analysis, and meta-regression analysis.
    Bhattacharyya A; Sarma P; Kaur H; Kumar S; Bhattacharyya J; Prajapat M; Prakash A; Sharma S; Reddy DH; Thota P; Bansal S; Gautam BS; Medhi B
    Indian J Pharmacol; 2021; 53(6):499-510. PubMed ID: 34975140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID Associated Mucormycosis: A Study on the Spectrum of Clinical, Biochemical and Radiological Findings in A Series of Ten Patients.
    Pal P; Chatterjee N; Ghosh S; Ray BK; Mukhopadhyay P; Bhunia K; Srivastava SR; Adhikari S; Barman D; Banerjee B; Mukhopadhyay M; Pal J
    J Assoc Physicians India; 2021 Oct; 69(10):11-12. PubMed ID: 34781648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Novel Study of Correlation of Lipid Parameters with Clinical Profile, Staging and Onset of Rhino Orbito Cerebral Mucormycosis Covid 19 Pandemic.
    V V; St K
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Iranian patients co-infected with COVID-19 and mucormycosis: the most common predisposing factor, clinical outcomes, laboratory markers and diagnosis, and drug therapies.
    Molaei H; Shojaeefar E; Nemati E; Khedmat L; Mojtahedi SY; Jonaidi Jafari N; Izadi M; Einollahi B
    Infect Dis (Lond); 2022 Aug; 54(8):600-613. PubMed ID: 35389322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetes mellitus and other underlying conditions in patients with coronavirus disease 2019 associated rhino-orbito-cerebral mucormycosis: a systematic review and meta-analysis.
    Zobairy H; Salem MM; Ghajarzadeh M; Mirmosayyeb O; Mirsalehi M
    J Laryngol Otol; 2022 Sep; 136(9):788-798. PubMed ID: 35514092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [COVID-19 associated mucormycosis. A case in Argentina].
    Aparicio M; Tuculet B; Rivolier MG; Forte A; Vila A
    Medicina (B Aires); 2022; 82(2):304-307. PubMed ID: 35417397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk Factors of COVID-19 Associated Mucormycosis (CAM) in Iranian Patients: A Single-Center Retrospective Study.
    Tavakolpour S; Irani S; Yekaninejad MS; Alimardi M; Hasibi M; Abdollahi H; Kazemi MA; Lotfi M; Shahbazian H; Nazemian Yazdi NA; Samimiardestani S; Firouzifar M; Farahbakhsh F; Mirzaee Goodarzi M; Feiz F; Salehinia F
    Mycopathologia; 2022 Dec; 187(5-6):469-479. PubMed ID: 36202942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dental and Oral Manifestations of COVID-19 Related Mucormycosis: Diagnoses, Management Strategies and Outcomes.
    Janjua OS; Shaikh MS; Fareed MA; Qureshi SM; Khan MI; Hashem D; Zafar MS
    J Fungi (Basel); 2021 Dec; 8(1):. PubMed ID: 35049983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A case report of rhino-facial mucormycosis in a non-diabetic patient with COVID-19: a systematic review of literature and current update.
    Mohammadi F; Badri M; Safari S; Hemmat N
    BMC Infect Dis; 2021 Sep; 21(1):906. PubMed ID: 34479495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Case series of four secondary mucormycosis infections in COVID-19 patients, the Netherlands, December 2020 to May 2021.
    Buil JB; van Zanten ARH; Bentvelsen RG; Rijpstra TA; Goorhuis B; van der Voort S; Wammes LJ; Janson JA; Melchers M; Heusinkveld M; Melchers WJG; Kuijper EJ; Verweij PE
    Euro Surveill; 2021 Jun; 26(23):. PubMed ID: 34114540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.